The Valley Desk

ArticleHistopathologyPublished

Comparison of intestinal histopathological changes following teclistamab, BCMA-directed CAR T, CD19-directed CAR T and rituximab therapies

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Histopathology
Published
Subject terms
Rituximab; Car T Therapy; Intestinal Tract Injury; Teclistamab; Lamina Propria Plasma Cell Depletion
PubMed ID
42732998
Added to directory
Source checked

Report a correction or request removal